Cargando…
P17-14. Fitness-informed HIV-1 Gag-p24 vaccine design
Autores principales: | Rolland, MM, Swain, VJ, Lanxon-Cookson, E, Rao, U, Henry, KR, Arts, EJ, Nickle, DC, Mullins, JI |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767799/ http://dx.doi.org/10.1186/1742-4690-6-S3-P296 |
Ejemplares similares
-
Fitness Costs of Mutations at the HIV-1 Capsid Hexamerization Interface
por: Manocheewa, Siriphan, et al.
Publicado: (2013) -
Pairwise Growth Competition Assay for Determining the Replication Fitness of Human Immunodeficiency Viruses
por: Manocheewa, Siriphan, et al.
Publicado: (2015) -
Amino-Acid Co-Variation in HIV-1 Gag Subtype C: HLA-Mediated Selection Pressure and Compensatory Dynamics
por: Rolland, Morgane, et al.
Publicado: (2010) -
Impact of Mutations in Highly Conserved Amino Acids of the HIV-1 Gag-p24 and Env-gp120 Proteins on Viral Replication in Different Genetic Backgrounds
por: Liu, Yi, et al.
Publicado: (2014) -
HIV-1 p24(gag) Derived Conserved Element DNA Vaccine Increases the Breadth of Immune Response in Mice
por: Kulkarni, Viraj, et al.
Publicado: (2013)